Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 EFEMP2 PCDHB15 TRPM2 PCDH11Y PCDHB3 ITIH4 FSTL1 CELSR3 PCDHGA12 LOXL2 PCDHGB4 PCDH10	1.49e-05	749	151	18	GO:0005509
GeneOntologyMolecularFunction	tRNA (cytidine) methyltransferase activity	METTL2A METTL2B TRDMT1	4.89e-05	10	151	3	GO:0016427
GeneOntologyMolecularFunction	tRNA methyltransferase activity	TRMT2A METTL2A METTL2B TRDMT1	1.22e-04	34	151	4	GO:0008175
GeneOntologyMolecularFunction	sulfur compound binding	TPMT FN1 EFEMP2 ITGA2 APP OGDH TKTL2 FSTL1 TAF1 GNS	1.79e-04	323	151	10	GO:1901681
GeneOntologyMolecularFunction	p53 binding	RFWD3 BANP TAF1 TP53BP1 HTT	2.95e-04	77	151	5	GO:0002039
GeneOntologyMolecularFunction	tRNA (cytidine-3-)-methyltransferase activity	METTL2A METTL2B	3.37e-04	4	151	2	GO:0052735
GeneOntologyMolecularFunction	proteoglycan binding	FN1 ITGA2 APP MFN2	5.96e-04	51	151	4	GO:0043394
GeneOntologyMolecularFunction	collagen receptor activity	DDR2 ITGA2	8.35e-04	6	151	2	GO:0038064
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PTPRG PTPRM PCDHGA12 PCDHGB4 PCDH10	6.61e-12	187	149	15	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PTPRG PTPRM PCDHGA12 ELFN1 PCDHGB4 PCDH10	1.07e-09	313	149	16	GO:0098742
GeneOntologyBiologicalProcess	meiotic sister chromatid cohesion involved in meiosis I	MEIKIN SGO2	5.18e-05	2	149	2	GO:0010789
GeneOntologyBiologicalProcess	positive regulation of sister chromatid cohesion	SMC5 SGO2 RAD21	5.84e-05	11	149	3	GO:0045876
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 ITGA2 ADD2 CELSR3 PTPRG PTPRM PCDHGA12 ELFN1 CD80 PCDHGB4 PCDH10 MEGF10	9.83e-05	1077	149	20	GO:0098609
GeneOntologyBiologicalProcess	regulation of sarcomere organization	MFN2 PRKD1 PROX1	1.00e-04	13	149	3	GO:0060297
Domain	Cadherin	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 FREM3 FREM1 CELSR3 PCDHGA12 PCDHGB4 PCDH10	3.26e-14	118	150	15	IPR002126
Domain	Cadherin_C	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4 PCDH10	9.74e-13	42	150	10	IPR032455
Domain	Cadherin_C_2	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4 PCDH10	9.74e-13	42	150	10	PF16492
Domain	Cadherin_2	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 PCDHGA12 PCDHGB4 PCDH10	3.82e-12	65	150	11	PF08266
Domain	Cadherin_N	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 PCDHGA12 PCDHGB4 PCDH10	3.82e-12	65	150	11	IPR013164
Domain	Cadherin_CS	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	4.12e-12	109	150	13	IPR020894
Domain	CADHERIN_1	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	6.59e-12	113	150	13	PS00232
Domain	Cadherin	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	6.59e-12	113	150	13	PF00028
Domain	CADHERIN_2	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	7.38e-12	114	150	13	PS50268
Domain	-	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	7.38e-12	114	150	13	2.60.40.60
Domain	CA	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	8.27e-12	115	150	13	SM00112
Domain	Cadherin-like	DCHS2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	9.25e-12	116	150	13	IPR015919
Domain	Cadherin_tail	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHGA12 PCDHGB4	1.58e-08	37	150	7	PF15974
Domain	Cadherin_CBD	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHGA12 PCDHGB4	1.58e-08	37	150	7	IPR031904
Domain	VWA	COL6A3 COL12A1 ITGA2 ITIH3 ITIH4	8.58e-05	56	150	5	PF00092
Domain	FN3	COL6A3 COL12A1 FN1 FSD2 GHR PTPRG PTPRM IL2RB	1.27e-04	185	150	8	SM00060
Domain	FN3	COL6A3 COL12A1 FN1 FSD2 GHR PTPRG PTPRM IL2RB	2.09e-04	199	150	8	PS50853
Domain	FN3_dom	COL6A3 COL12A1 FN1 FSD2 GHR PTPRG PTPRM IL2RB	2.91e-04	209	150	8	IPR003961
Domain	Tyr_Pase_AS	DUSP18 DUSP8 PTPRG PTPRM SSH2	3.03e-04	73	150	5	IPR016130
Domain	MeTrfase	METTL2A METTL2B	3.80e-04	4	150	2	IPR026113
Domain	K_chnl_volt-dep_Kv3	KCNC2 KCNC3	3.80e-04	4	150	2	IPR003974
Domain	-	TPMT NDUFAF5 TRMT2A METTL2A METTL2B TRDMT1	4.18e-04	120	150	6	3.40.50.150
Domain	SAM-dependent_MTases	TPMT NDUFAF5 TRMT2A METTL2A METTL2B TRDMT1	4.57e-04	122	150	6	IPR029063
Domain	VWFA	COL6A3 COL12A1 ITGA2 ITIH3 ITIH4	5.19e-04	82	150	5	PS50234
Domain	VWA	COL6A3 COL12A1 ITGA2 ITIH3 ITIH4	5.79e-04	84	150	5	SM00327
Domain	TYR_PHOSPHATASE_1	DUSP18 DUSP8 PTPRG PTPRM SSH2	6.45e-04	86	150	5	PS00383
Domain	TYR_PHOSPHATASE_dom	DUSP18 DUSP8 PTPRG PTPRM SSH2	6.80e-04	87	150	5	IPR000387
Domain	TYR_PHOSPHATASE_2	DUSP18 DUSP8 PTPRG PTPRM SSH2	6.80e-04	87	150	5	PS50056
Domain	Pentatricopeptide_repeat	XAB2 PIP5K1B HTT	7.99e-04	23	150	3	IPR002885
Domain	-	DUSP18 DUSP8 PTPRG PTPRM SSH2	8.77e-04	92	150	5	3.90.190.10
Domain	-	COL6A3 COL12A1 FN1 FSD2 PKHD1L1 GHR FCRL1 FCER1A PTPRG PTPRM CD80 KIR2DL1 KIR2DL2 IL2RB	9.26e-04	663	150	14	2.60.40.10
Domain	ITI_HC_C	ITIH3 ITIH4	9.41e-04	6	150	2	IPR010600
Domain	Methyltransf_12	METTL2A METTL2B	9.41e-04	6	150	2	IPR013217
Domain	Methyltransf_12	METTL2A METTL2B	9.41e-04	6	150	2	PF08242
Domain	ITI_HC_C	ITIH3 ITIH4	9.41e-04	6	150	2	PF06668
Domain	Prot-tyrosine_phosphatase-like	DUSP18 DUSP8 PTPRG PTPRM SSH2	1.22e-03	99	150	5	IPR029021
Domain	VWF_A	COL6A3 COL12A1 ITGA2 ITIH3 ITIH4	1.22e-03	99	150	5	IPR002035
Domain	Ig-like_fold	COL6A3 COL12A1 FN1 FSD2 PKHD1L1 GHR FCRL1 FCER1A PTPRG PTPRM CD80 KIR2DL1 KIR2DL2 IL2RB	1.68e-03	706	150	14	IPR013783
Domain	Transketolase-like_Pyr-bd	OGDH TKTL2	1.74e-03	8	150	2	IPR005475
Domain	VIT	ITIH3 ITIH4	1.74e-03	8	150	2	PF08487
Domain	Transket_pyr	OGDH TKTL2	1.74e-03	8	150	2	SM00861
Domain	Transket_pyr	OGDH TKTL2	1.74e-03	8	150	2	PF02779
Domain	VIT	ITIH3 ITIH4	1.74e-03	8	150	2	SM00609
Domain	DUSP	DUSP18 DUSP8 SSH2	1.94e-03	31	150	3	IPR024950
Domain	fn3	COL12A1 FN1 FSD2 GHR PTPRG PTPRM	1.99e-03	162	150	6	PF00041
Domain	Calx_beta	FREM3 FREM1	2.22e-03	9	150	2	IPR003644
Domain	Calx-beta	FREM3 FREM1	2.22e-03	9	150	2	PF03160
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	1.46e-15	80	152	12	10716726
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	1.85e-14	72	152	11	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 PCDHGA12 PCDHGB4 PCDH10	2.54e-14	74	152	11	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDH11Y PCDHB3 PCDHGA12 PCDHGB4 PCDH10	4.02e-14	77	152	11	10835267
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4 PCDH10	4.41e-13	68	152	10	11230163
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGB5 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4	1.91e-07	57	152	6	32633719
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TTC28 SORBS1 SMC5 FHIP2A GANAB KIDINS220 AKAP9 MCM3AP MFN2 PACS2 HERC3 PCDH10	2.62e-07	407	152	12	12693553
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	COL6A3 COL12A1 FN1 FSD2 SORBS1 PREPL CEP170 NEDD9 AKAP9 APPL2 FSTL1 TAF1 MED13	3.20e-07	497	152	13	23414517
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGB5 PCDHGA6 PCDHGA12 PCDHGB4	4.61e-07	15	152	4	23515096
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 ITIH3 FREM1 ITIH4	7.79e-07	167	152	8	22159717
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NPC1 DCHS2 FN1 TTC28 TTLL5 EFEMP2 ARFGEF2 SORBS1 MYNN APP PREPL XAB2 APPL2 CELSR3 SUPT5H SCG2 TAF1 WDFY3 MED13 EXOC4	9.11e-07	1285	152	20	35914814
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TTC28 SORBS1 XAB2 CELSR3 MCM3AP MED13 MEGF10	1.79e-06	130	152	7	12421765
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	COL6A3 FN1 APP ITIH3 ITIH4 FSTL1 PTPRG PTPRM C1QA	2.14e-06	257	152	9	16335952
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 LOXL2	2.22e-06	86	152	6	28327460
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	NPC1 CCP110 ZNF573 COL12A1 ZNF148 EFEMP2 ITGA2 SBNO2 CEP170 NEDD9 AP3S1 CD80 SUPT5H WDR41 TAF1 METTL2A MED13 TP53BP1 METTL2B	4.02e-06	1293	152	19	15342556
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TTC28 FHIP2A XAB2 RFWD3 SBNO2 GTPBP2 TRMT2A SUPT5H CDK13 TRAM1 ANKRD17 NMT1 EXOC4	6.15e-06	650	152	13	38777146
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGB5 PCDHGA6 PCDHGA12 PCDHGB4	6.62e-06	28	152	4	15347688
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	COL6A3 FREM3 FREM1	9.60e-06	10	152	3	15345741
Pubmed	The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis.	FN1 SORBS1 IDH3A OGDH ADD2 NEDD9 MCM3AP ANKRD17	1.33e-05	245	152	8	19521500
Pubmed	Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).	COL12A1 COL16A1 FN1 KPRP ITIH4 FSTL1 LOXL2 GNAI2	1.41e-05	247	152	8	39238192
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGB5 PCDHGA6 PCDHGA12 PCDHGB4	1.47e-05	34	152	4	22884324
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	SORBS1 APP NUP54 CEP170 AKAP9 EXOC4	1.53e-05	120	152	6	31413325
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SATB2 ZNF148 TTC28 NELFCD ZDBF2 IDH3A ANKRD17 TAF1 EXOC4 PROX1	1.66e-05	418	152	10	34709266
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ITGA2 APP RGP1 ADD2 GANAB KIDINS220 APPL2 PTPRM GNS EXOC4	1.77e-05	421	152	10	36976175
Pubmed	Amyloid Precursor Protein Haploinsufficiency Preferentially Mediates Brain Iron Accumulation in Mice Transgenic for The Huntington's Disease Mutation.	APP HTT	1.90e-05	2	152	2	28550267
Pubmed	Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia.	ITIH3 ITIH4	1.90e-05	2	152	2	24461634
Pubmed	The Effects of Extracellular Serum Concentration on APP Processing in Npc1-Deficient APP-Overexpressing N2a Cells.	NPC1 APP	1.90e-05	2	152	2	29052144
Pubmed	A Potential Role for the Amyloid Precursor Protein in the Regulation of Interferon Signaling, Cholesterol Homeostasis, and Tau Phosphorylation in Niemann-Pick Disease Type C.	NPC1 APP	1.90e-05	2	152	2	39202426
Pubmed	PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling.	FN1 PTPRM	1.90e-05	2	152	2	34225581
Pubmed	MEGF10 functions as a receptor for the uptake of amyloid-β.	APP MEGF10	1.90e-05	2	152	2	20828568
Pubmed	Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer.	GHR NEDD9	1.90e-05	2	152	2	24676793
Pubmed	ITIH3 and ITIH4 polymorphisms and depressive symptoms during pregnancy in Japan: the Kyushu Okinawa Maternal and Child Health Study.	ITIH3 ITIH4	1.90e-05	2	152	2	29992445
Pubmed	Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin.	APP HTT	1.90e-05	2	152	2	32452382
Pubmed	Fibronectin binds to the C1q component of complement.	FN1 C1QA	1.90e-05	2	152	2	6981115
Pubmed	Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.	NPC1 APP	1.90e-05	2	152	2	22869680
Pubmed	Loss of amyloid precursor protein in a mouse model of Niemann-Pick type C disease exacerbates its phenotype and disrupts tau homeostasis.	NPC1 APP	1.90e-05	2	152	2	21303697
Pubmed	Collagen XVI is a neural component of the developing and regenerating dorsal root ganglia extracellular matrix.	COL16A1 FN1	1.90e-05	2	152	2	17169544
Pubmed	Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.	FN1 LOXL2	1.90e-05	2	152	2	31759052
Pubmed	KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals.	KIR2DL1 KIR2DL2	1.90e-05	2	152	2	31519864
Pubmed	hSnm1 colocalizes and physically associates with 53BP1 before and after DNA damage.	DCLRE1A TP53BP1	1.90e-05	2	152	2	12446782
Pubmed	Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein.	APP GNAI2	1.90e-05	2	152	2	20932279
Pubmed	Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 protein.	NPC1 APP	1.90e-05	2	152	2	23382922
Pubmed	Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D.	KIDINS220 PRKD1	1.90e-05	2	152	2	10998417
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SORBS1 LMTK3 PREPL ITIH4 CEP170 AKAP9 MFN2 SEPTIN11 ANKRD17 KIF4B PRKD1 WDFY3 SSH2 TP53BP1 PROX1	2.28e-05	963	152	15	28671696
Pubmed	Quantitative trait loci affecting the 3D skull shape and size in mouse and prioritization of candidate genes in-silico.	COL16A1 TAF1B ITGA2 FREM1	2.56e-05	39	152	4	25859222
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL6A3 COL12A1 COL16A1 FN1 ITIH4 C1QA	2.98e-05	135	152	6	28675934
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	PCDHGB5 PCDHGA6 PCDHGA12 PCDHGB4	4.15e-05	44	152	4	19029045
Pubmed	SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis.	SATB2 SMC5 TP53BP1	4.40e-05	16	152	3	33200984
Pubmed	Human inter-alpha-trypsin inhibitor heavy chain H3 gene. Genomic organization, promoter analysis, and gene linkage.	ITIH3 ITIH4	5.68e-05	3	152	2	9756925
Pubmed	Deficiency in SNM1 abolishes an early mitotic checkpoint induced by spindle stress.	DCLRE1A TP53BP1	5.68e-05	3	152	2	15542852
Pubmed	Genomic organization, nucleotide sequence, and cellular distribution of a Shaw-related potassium channel gene, Kv3.3, and mapping of Kv3.3 and Kv3.4 to human chromosomes 19 and 1.	KCNC2 KCNC3	5.68e-05	3	152	2	1740329
Pubmed	Novel collectin/C1q receptor mediates mast cell activation and innate immunity.	ITGA2 C1QA	5.68e-05	3	152	2	16166590
Pubmed	Pharmacophore-based screening targeted at upregulated FN1, MMP-9, APP reveals therapeutic compounds for nasopharyngeal carcinoma.	FN1 APP	5.68e-05	3	152	2	26773938
Pubmed	Apoptosis. Dead end for neurodegeneration?	APP HTT	5.68e-05	3	152	2	10353238
Pubmed	Comparative assignments of the genes of the inter-alpha-inhibitor family in human and mouse: ITIH4 is close to ITIH1 and ITIH3, on HSA 3 and MMU 14.	ITIH3 ITIH4	5.68e-05	3	152	2	9126497
Pubmed	Molecular structure and interaction of recombinant human type XVI collagen.	COL16A1 FN1	5.68e-05	3	152	2	15165854
Pubmed	GGA1 overexpression attenuates amyloidogenic processing of the amyloid precursor protein in Niemann-Pick type C cells.	NPC1 APP	5.68e-05	3	152	2	24866237
Pubmed	Mitofusin 1 and 2 overexpression reduces AβO-mediated ER stress and apoptosis in N2a APPswe cells.	APP MFN2	5.68e-05	3	152	2	39097901
Pubmed	The C-terminal region of A-kinase anchor protein 350 (AKAP350A) enables formation of microtubule-nucleation centers and interacts with pericentriolar proteins.	CEP170 AKAP9	5.68e-05	3	152	2	29054927
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2	5.68e-05	3	152	2	19549382
Pubmed	DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification.	METTL2A METTL2B	5.68e-05	3	152	2	32427860
Pubmed	Kv3 channels contribute to the delayed rectifier current in small cultured mouse dorsal root ganglion neurons.	KCNC2 KCNC3	5.68e-05	3	152	2	22673617
Pubmed	Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease.	NPC1 APP	5.68e-05	3	152	2	20497909
Pubmed	Entry of Bacillus anthracis spores into epithelial cells is mediated by the spore surface protein BclA, integrin α2β1 and complement component C1q.	ITGA2 C1QA	5.68e-05	3	152	2	21134100
Pubmed	Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.	TP53BP1 EXOC4	5.68e-05	3	152	2	26283729
Pubmed	Perlecan domain V inhibits α2 integrin-mediated amyloid-β neurotoxicity.	ITGA2 APP	5.68e-05	3	152	2	21126803
Pubmed	Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.	KIR2DL1 KIR2DL2	5.68e-05	3	152	2	15879158
Pubmed	Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.	NPC1 APP	5.68e-05	3	152	2	20607864
Pubmed	Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo.	NPC1 APP	5.68e-05	3	152	2	12843267
Pubmed	Molecular cloning and characterization of beta-1,4-galactosyltransferase expressed in mouse testis.	WDFY3 RAD21	5.68e-05	3	152	2	9108238
Pubmed	Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.	CDK13 PRKD1	5.68e-05	3	152	2	27479907
Pubmed	Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.	FN1 ITGA2 PROX1	6.36e-05	18	152	3	19686679
Pubmed	Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.	COL6A3 COL12A1 EFEMP2 GNAI2	6.91e-05	50	152	4	24769233
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL6A3 COL12A1 FN1 ITGA2	6.91e-05	50	152	4	23658023
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	NELFCD SUPT5H TAF1	7.53e-05	19	152	3	23518577
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SMC5 PCDHGA12 MCM3AP PACS2 MED13	1.01e-04	105	152	5	9628581
Pubmed	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	20056126
Pubmed	Postmitotic Prox1 Expression Controls the Final Specification of Cortical VIP Interneuron Subtypes.	ELFN1 PROX1	1.13e-04	4	152	2	34380763
Pubmed	Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease.	KCNC2 KCNC3	1.13e-04	4	152	2	21912965
Pubmed	Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.	NPC1 APP	1.13e-04	4	152	2	20864542
Pubmed	Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.	FN1 C1QA	1.13e-04	4	152	2	1875953
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM3 FREM1	1.13e-04	4	152	2	18563433
Pubmed	Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	25037176
Pubmed	Collagen XVI harbors an integrin alpha1 beta1 recognition site in its C-terminal domains.	COL16A1 ITGA2	1.13e-04	4	152	2	16754661
Pubmed	Localization of Shaw-related K+ channel genes on mouse and human chromosomes.	KCNC2 KCNC3	1.13e-04	4	152	2	8111118
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	26542066
Pubmed	Identification of a novel family of putative methyltransferases that interact with human and Drosophila presenilins.	METTL2A METTL2B	1.13e-04	4	152	2	11738826
Pubmed	Loci with genome-wide associations with schizophrenia in the Han Chinese population.	ITIH3 ITIH4	1.13e-04	4	152	2	26206863
Pubmed	Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains.	PTPRG PTPRM	1.13e-04	4	152	2	8759740
Pubmed	De Novo Coding Variants Are Strongly Associated with Tourette Disorder.	FN1 CELSR3	1.13e-04	4	152	2	28472652
Pubmed	HLA-C and KIR genes in hepatitis C virus infection.	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	16571411
Pubmed	[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	18543232
Pubmed	Mutually exclusive substrate selection strategy by human m3C RNA transferases METTL2A and METTL6.	METTL2A METTL2B	1.13e-04	4	152	2	34268557
Pubmed	Multiple beta 1 integrins mediate enhancement of human airway smooth muscle cytokine secretion by fibronectin and type I collagen.	FN1 ITGA2	1.13e-04	4	152	2	15699160
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2	1.13e-04	4	152	2	18269867
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	COL12A1 FN1 EFEMP2 GHR FSTL1 LOXL2 C1QA	1.16e-04	248	152	7	24006456
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGA6 PCDHB15 PCDHB3 PCDHGB4	1.24e-04	58	152	4	30377227
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL6A3 COL12A1 COL16A1 FN1 ITIH4 LOXL2	1.26e-04	175	152	6	28071719
Pubmed	Genome-wide association study identifies five new schizophrenia loci.	ITIH3 ITIH4 PTPRG	1.36e-04	23	152	3	21926974
Pubmed	Generation and annotation of the DNA sequences of human chromosomes 2 and 4.	CHRNA9 TAF1B RNF149 FREM3 ADD2 SCG2 SGO2 WDFY3 HTT	1.51e-04	442	152	9	15815621
Interaction	PCDHGB2 interactions	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB3 PCDHGA12 PCDHGB4 PCDH10 DCBLD2	8.23e-13	44	151	10	int:PCDHGB2
Interaction	PCDHGB1 interactions	TTC28 PCDHGB5 PCDHGB3 CELSR3 PCDHGA12 PCDHGB4 PCDH10	1.79e-06	77	151	7	int:PCDHGB1
Interaction	PCDHA9 interactions	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGA6 PCDHGA12	3.78e-06	32	151	5	int:PCDHA9
Interaction	PCDHGB4 interactions	PCDHGB5 PCDHGB3 RNF149 CELSR3 PCDHGB4 PCDH10	5.20e-06	59	151	6	int:PCDHGB4
Interaction	PCDHGB5 interactions	PCDHGB5 PCDHGB3 PCDHB3 CELSR3 PCDHGB4	1.69e-05	43	151	5	int:PCDHGB5
Interaction	PCDHGB3 interactions	PCDHGB5 PCDHGB3 PCDHGB4	2.25e-05	8	151	3	int:PCDHGB3
Interaction	METTL2B interactions	CENPU APP METTL2A METTL2B	2.40e-05	23	151	4	int:METTL2B
Interaction	METTL2A interactions	NDUFAF5 PREPL METTL2A METTL2B	2.40e-05	23	151	4	int:METTL2A
Interaction	MRAP2 interactions	RNF149 ARFGEF2 ABCB6 APP KIDINS220 WDR41	2.45e-05	77	151	6	int:MRAP2
Interaction	RGS18 interactions	APP GNAI2 HTT	3.35e-05	9	151	3	int:RGS18
Interaction	PCDHGC3 interactions	CHRNA9 PCDHGB3 PCDHGA6 APP PTPRG	5.20e-05	54	151	5	int:PCDHGC3
Cytoband	5q31	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4	1.96e-10	115	152	9	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 MEIKIN PCDHB15 PCDHB3 PCDHGA12 PCDHGB4	6.80e-08	298	152	10	chr5q31
GeneFamily	Clustered protocadherins	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHB15 PCDHB3 PCDHGA12 PCDHGB4	7.19e-11	64	100	9	20
GeneFamily	Fibronectin type III domain containing	COL12A1 FN1 FSD2 GHR PTPRG PTPRM ELFN1	2.99e-05	160	100	7	555
GeneFamily	Potassium voltage-gated channels	KCNH7 KCNC2 KCNC3	1.40e-03	40	100	3	274
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH10	1.93e-03	12	100	2	21
GeneFamily	Collagens	COL6A3 COL12A1 COL16A1	2.10e-03	46	100	3	490
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 ITGA2 FSTL1 SCG2 LOXL2	2.54e-06	200	151	9	M5930
Coexpression	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	SATB2 PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDH11Y PCDHGB4 PROX1	5.94e-06	222	151	9	M16955
Coexpression	PILON_KLF1_TARGETS_UP	FN1 EXD1 TTLL5 DUSP8 ITIH3 NUP54 GHR C2CD3 FSTL1 LOXL2 C1QA DCBLD2 MED13	7.41e-06	503	151	13	M2226
Coexpression	BRUINS_UVC_RESPONSE_LATE	NPC1 TPMT COL6A3 COL12A1 FN1 MEIKIN EFEMP2 CENPU APP SMC5 GHR FSTL1 CELSR3 PTPRG PTPRM TRAM1 LOXL2 SEPTIN11 NMT1 DCBLD2	8.81e-06	1136	151	20	M2247
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SATB2 ZNF148 TTC28 DDR2 HMGXB4 APP SMC5 CEP170 C2CD3 KIDINS220 AKAP9 PTPRM CDK13 ANKRD17 WDFY3 MED13 TP53BP1	9.49e-06	856	151	17	M4500
Coexpression	PILON_KLF1_TARGETS_UP	FN1 EXD1 TTLL5 DUSP8 ITIH3 NUP54 GHR C2CD3 FSTL1 LOXL2 C1QA DCBLD2 MED13	1.60e-05	541	151	13	MM1061
Coexpression	BRUINS_UVC_RESPONSE_LATE	NPC1 TPMT COL6A3 COL12A1 FN1 MEIKIN EFEMP2 CENPU APP SMC5 GHR FSTL1 CELSR3 PTPRG PTPRM TRAM1 LOXL2 SEPTIN11 NMT1 DCBLD2	1.90e-05	1198	151	20	MM1062
Coexpression	GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN	ZWILCH ZDBF2 SLC2A2 C16orf46 PTPRM SCG2 PIP5K1B MEGF10	2.11e-05	199	151	8	M9434
Coexpression	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	COL6A3 COL16A1 FN1 EFEMP2 EVI2A FSTL1 PTPRM LOXL2 SEPTIN11 C1QA	3.94e-05	352	151	10	M17471
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	CCP110 ZWILCH KCNH7 CENPU ERI1 IDH3A SMC5 CELSR3 SGO2 KIF4B HERC3 DCBLD2 TP53BP1 PROX1	4.12e-05	680	151	14	MM456
Coexpression	CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL	COL6A3 COL12A1 COL16A1 EFEMP2 FSTL1 SEPTIN11	6.12e-05	117	151	6	M39300
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	PRUNE2 TTC28 PTPRG PTPRM WDFY3 SSH2 EXOC4	7.48e-05	176	151	7	M39223
Coexpression	NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER	EFEMP2 ITIH4 LOXL2 C1QA	9.08e-05	41	151	4	M47988
Coexpression	GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN	COL12A1 FSD2 CELSR3 DCLRE1A DCBLD2 BANK1	1.05e-04	129	151	6	M354
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1 LOXL2 MEGF10	9.14e-11	198	152	11	55d2ed345101bec4b73f1242ba8c4d73073b7e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1 LOXL2 MEGF10	9.14e-11	198	152	11	8602a518b5913625b1dd3cbc3c7e6efde0d5d942
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 PCDHGB7 EFEMP2 DDR2 FSTL1 LOXL2 MEGF10	1.61e-09	197	152	10	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 FSTL1 PTPRG LOXL2 SEPTIN11 MEGF10	1.61e-09	197	152	10	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 COL12A1 COL16A1 FN1 TTC28 DDR2 FSTL1 PTPRG SEPTIN11 PRKD1	1.61e-09	197	152	10	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 PTPRG LOXL2 MEGF10	1.61e-09	197	152	10	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 COL16A1 FN1 TTC28 DDR2 FREM1 GHR FSTL1 PTPRG SEPTIN11	1.69e-09	198	152	10	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11 PRKD1	1.78e-09	199	152	10	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 EFEMP2 DDR2 FREM1 AKAP9 FSTL1 PRKD1	1.86e-09	200	152	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 TTC28 PCDHGB5 EFEMP2 DDR2 FREM1 AKAP9 FSTL1 PRKD1	1.86e-09	200	152	10	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 MEGF10	1.86e-09	200	152	10	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1 PTPRG PRKD1	1.80e-08	188	152	9	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL16A1 FN1 EFEMP2 DDR2 APP FSTL1 LOXL2 DCBLD2	2.16e-08	192	152	9	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 COL16A1 FN1 TTC28 DDR2 GHR FSTL1 PTPRG PRKD1	2.69e-08	197	152	9	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL6A3 COL16A1 FN1 DDR2 GHR FSTL1 PTPRG SEPTIN11 PRKD1	2.81e-08	198	152	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1	2.81e-08	198	152	9	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1	2.81e-08	198	152	9	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 MEGF10	2.94e-08	199	152	9	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 MEGF10	2.94e-08	199	152	9	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL6A3 COL16A1 FN1 TTC28 DDR2 FREM1 GHR FSTL1 PTPRG	2.94e-08	199	152	9	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 SEPTIN11	3.07e-08	200	152	9	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11	3.07e-08	200	152	9	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11	3.07e-08	200	152	9	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 SEPTIN11	3.07e-08	200	152	9	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 COL16A1 FN1 PCDHGB7 DDR2 FSTL1 PCDH10	2.10e-07	181	152	8	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 COL16A1 FN1 PCDHGB7 DDR2 FSTL1 PCDH10	2.10e-07	181	152	8	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	COL6A3 COL12A1 COL16A1 EFEMP2 DDR2 FSTL1 LOXL2 MEGF10	2.19e-07	182	152	8	812dac35b9aa05be48258082e007f6c00e7b4dd8
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	PRUNE2 COL6A3 COL12A1 FN1 TTC28 SORBS1 PTPRG PRKD1	2.70e-07	187	152	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A3 COL16A1 FN1 DDR2 FREM1 GHR FSTL1 PTPRG	3.04e-07	190	152	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL12A1 COL16A1 DDR2 FREM3 FSTL1 LOXL2 MEGF10	3.04e-07	190	152	8	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL12A1 COL16A1 DDR2 FREM3 FSTL1 LOXL2 MEGF10	3.04e-07	190	152	8	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 GHR FSTL1	3.17e-07	191	152	8	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 PCDHGB7 PTPRG MEGF10	3.43e-07	193	152	8	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL16A1 FN1 EFEMP2 DDR2 FREM1 FSTL1 PRKD1	3.57e-07	194	152	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	3.57e-07	194	152	8	ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL6A3 FN1 TTC28 DDR2 FREM1 GHR PTPRG SEPTIN11	3.86e-07	196	152	8	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 COL16A1 FN1 DDR2 FREM1 GHR FSTL1 PTPRG	3.86e-07	196	152	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	4.01e-07	197	152	8	63b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	4.01e-07	197	152	8	fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	4.16e-07	198	152	8	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	4.16e-07	198	152	8	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 FSTL1 LOXL2 SEPTIN11	4.33e-07	199	152	8	84545ced0c792bc77980a50d65e484eab648d47e
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 COL16A1 EFEMP2 DDR2 GHR FSTL1 LOXL2	4.33e-07	199	152	8	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1	4.33e-07	199	152	8	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 EFEMP2 DDR2 FREM1 FSTL1	4.33e-07	199	152	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 PCDHGB5 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11	4.33e-07	199	152	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	facs-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL16A1 EFEMP2 DDR2 APP FSTL1 TRAM1 LOXL2	4.33e-07	199	152	8	1ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2 SEPTIN11	4.33e-07	199	152	8	36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 COL16A1 EFEMP2 DDR2 GHR FSTL1 LOXL2	4.33e-07	199	152	8	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 DDR2 GHR FSTL1 LOXL2	4.33e-07	199	152	8	6200618e029063486719479c41eaf31798bd13cf
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A3 FN1 TTC28 DDR2 FREM1 GHR FSTL1 PTPRG	4.33e-07	199	152	8	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1	4.33e-07	199	152	8	f2ad641f36c577ff7019e88ad6b73ed7e46d8c74
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 FSTL1 LOXL2 SEPTIN11	4.33e-07	199	152	8	da016849b804fbf80edbfa8f8f56c9df8bbf2d51
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 FSTL1 LOXL2 SEPTIN11	4.33e-07	199	152	8	3cf62666ffd000427fdbb7cf940793f98c3ed29c
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 COL16A1 EFEMP2 DDR2 GHR FSTL1 LOXL2	4.33e-07	199	152	8	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	facs-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL16A1 EFEMP2 DDR2 APP FSTL1 TRAM1 LOXL2	4.33e-07	199	152	8	67f78c070c56e44fba36542041bf7fa1c291807c
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 MEGF10	4.49e-07	200	152	8	16a7c398626b6e82b394eb3ef013bda3a788659d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11 PRKD1	4.49e-07	200	152	8	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 EFEMP2 DDR2 FREM1 FSTL1 SEPTIN11 PRKD1	4.49e-07	200	152	8	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 COL6A3 COL12A1 COL16A1 FN1 DDR2 PCDH11Y PTPRG	4.49e-07	200	152	8	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	4dbe21cb63569f28c7017cda065ea5ee00d7254e
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	8256511b099c3eab8e33194f90c9ff354e7cfe8e
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 COL16A1 FN1 DDR2 FREM1 GHR FSTL1 PTPRG	4.49e-07	200	152	8	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	e663995fc44c340d878d66b278b7b5c2ff784301
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1	4.49e-07	200	152	8	780d47f8eff630020dfae32218de495a7e9dbad6
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 SATB2 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1	4.49e-07	200	152	8	28dd127787a57276253548d1f030814b1af64481
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	bde938e5a18844fb8cc1d1be5a086809f7e2b97d
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	2cb8a39a12522a9643c6244d5e94cb4559868bb9
ToppCell	Lung_Parenchyma-Severe-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	6ce8e2cf689523993d909a27daec3d6a5824d13c
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	907427e85cebe5a18c8a310e2ffa0e180ea3cb77
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef
ToppCell	Parenchyma_COVID-19-Stromal-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 SEPTIN11	4.49e-07	200	152	8	8472baa74c48b67c5f08223025885c833458290b
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL16A1 FN1 PCDHGB5 DDR2 FREM1 FSTL1 SEPTIN11	4.49e-07	200	152	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	(5)_Fibroblast-B_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 FSTL1 LOXL2	4.49e-07	200	152	8	9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8
ToppCell	Severe-B_naive-5\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FN1 NOXA1 SLC2A2 ADD2 FSIP2 DCBLD2 BANK1	1.17e-06	157	152	7	a57ee4a6febdff3ee3d1645836695e6e7c055cf8
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB2 PCDHB15 ITIH3 FSTL1 PTPRG KCNC2 PRKD1	1.98e-06	170	152	7	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB2 PCDHB15 ITIH3 FSTL1 PTPRG KCNC2 PRKD1	1.98e-06	170	152	7	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 COL12A1 COL16A1 FN1 PCDHB3 SORBS1 FSTL1	3.35e-06	184	152	7	54e5b63f55b8d6eccad53d389ea9c78f991e1414
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 COL12A1 COL16A1 FN1 PCDHB3 SORBS1 FSTL1	3.35e-06	184	152	7	7b5678718719020b52e7c2a7bd9797987defd7ff
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 TTC28 DDR2 FREM1 GHR FSTL1 PTPRG	3.47e-06	185	152	7	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A3 COL12A1 DDR2 DUSP8 GHR FSTL1 MEGF10	3.47e-06	185	152	7	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 EFEMP2 GHR FSTL1 PCDHGA12 PRKD1	3.73e-06	187	152	7	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL6A3 COL16A1 FN1 ITGA2 FREM1 GHR PTPRG	3.73e-06	187	152	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 EFEMP2 GHR FSTL1 PCDHGA12 PRKD1	3.73e-06	187	152	7	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 EFEMP2 GHR FSTL1 PCDHGA12 PRKD1	3.73e-06	187	152	7	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL16A1 FN1 PCDHGA6 EFEMP2 FSTL1 MEGF10	3.86e-06	188	152	7	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL16A1 DDR2 OVOS2 FSTL1 PTPRM SCG2 TRDMT1	3.86e-06	188	152	7	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DDR2 OVOS2 FREM1 PTPRM SCG2 PIP5K1B PROX1	4.00e-06	189	152	7	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SATB2 FREM1 ANKRD17 PRKD1 WDFY3 EXOC4 PROX1	4.00e-06	189	152	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL6A3 COL16A1 FN1 EFEMP2 FREM1 GHR SEPTIN11	4.00e-06	189	152	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DDR2 OVOS2 FREM1 PTPRM SCG2 PIP5K1B PROX1	4.28e-06	191	152	7	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A3 COL12A1 EFEMP2 DDR2 GHR FSTL1 LOXL2	4.28e-06	191	152	7	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TTC28 NEDD9 AP3S1 AKAP9 PRKD1 MED13 RAD21	4.43e-06	192	152	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL16A1 FN1 EFEMP2 FSTL1 SCG2 MEGF10	4.43e-06	192	152	7	f88aba74d6e8c594c32fe2bc095b5da28b4b28e9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL16A1 FN1 DDR2 FREM1 FSTL1 PRKD1	4.43e-06	192	152	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 TTC28 SLC2A2 GHR RAD51AP2 SCG2 GNS	4.43e-06	192	152	7	1304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL16A1 EFEMP2 DDR2 FREM1 FSTL1 PRKD1	4.43e-06	192	152	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL16A1 FN1 EFEMP2 FSTL1 SCG2 MEGF10	4.43e-06	192	152	7	41a8326cd5bc19ad5041068501bab4c72399222e
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PRUNE2 COL6A3 COL12A1 FN1 DDR2 SORBS1 LOXL2	4.59e-06	193	152	7	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 COL12A1 FN1 TTC28 DDR2 PTPRG PRKD1	4.59e-06	193	152	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
Computational	Adhesion molecules.	COL6A3 COL12A1 COL16A1 FN1 EFEMP2 DDR2 ITGA2 NEDD9	3.60e-05	141	96	8	MODULE_122
Drug	DMSe	TPMT COL6A3 COL12A1 COL16A1 FN1 ARFGEF2 ITGA2 APP SBNO2	2.62e-07	132	152	9	CID000020796
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	NPC1 FN1 ITGA2 APP GANAB KIDINS220 PTPRG MCM3AP GNS	1.02e-06	155	152	9	6817_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	NDUFAF5 PCDHGB6 TTLL5 SORBS1 SBNO2 FCER1A CELSR3 CD80 PRKD1	7.02e-06	196	152	9	5111_UP
Drug	hydroxylysine	COL6A3 COL12A1 COL16A1 FN1 OGDH LOXL2 C1QA	8.68e-06	109	152	7	CID000001029
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	NPC1 FN1 APP GANAB KIDINS220 PTPRG LOXL2 GNS	1.30e-05	161	152	8	3556_DN
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB7 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHGA12 PCDHGB4 HERC3	2.84e-09	71	149	8	EFO_0007878, EFO_0007979
Disease	mental development measurement	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 PCDHGB4	1.50e-07	25	149	5	EFO_0008230
Disease	thiopurine metabolite measurement, response to mercaptopurine	NHLRC1 TPMT	2.53e-05	2	149	2	EFO_0007853, EFO_0009693
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 APP C1QA	3.48e-05	13	149	3	DOID:11758 (biomarker_via_orthology)
Disease	Ullrich congenital muscular dystrophy	COL6A3 COL12A1	1.51e-04	4	149	2	cv:C4551860
Disease	Bethlem myopathy	COL6A3 COL12A1	1.51e-04	4	149	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A3 COL12A1	1.51e-04	4	149	2	C1834674
Disease	Ullrich congenital muscular dystrophy 1	COL6A3 COL12A1	1.51e-04	4	149	2	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A3 COL12A1	1.51e-04	4	149	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A3 COL12A1	1.51e-04	4	149	2	DOID:0050558 (is_implicated_in)
Disease	Sarcosine measurement	PCDHGB3 PCDHGA6 PCDHGB4	2.08e-04	23	149	3	EFO_0021668
Disease	mean platelet volume	NHLRC1 PCDHGB7 TTC28 PCDHGB6 PCDHGB5 PCDHGB3 NELFCD PCDHGA6 SIDT1 SORBS1 ITGA2 PCDHGA12 PCDHGB4 BANK1 HTT	2.13e-04	1020	149	15	EFO_0004584
Disease	intermediate coronary syndrome (is_implicated_in)	ITGA2 ITIH4	2.51e-04	5	149	2	DOID:8805 (is_implicated_in)
Disease	urate measurement, bone density	TTC28 TAF1B HMGXB4 OGDH PREPL FREM1 NEDD9 FSIP2 KIDINS220 PTPRG LOXL2	3.22e-04	619	149	11	EFO_0003923, EFO_0004531
Disease	inter-alpha-trypsin inhibitor heavy chain h4 measurement	DDR2 ITIH4	5.23e-04	7	149	2	EFO_0020481
Disease	2-hydroxystearate measurement	MUC19 ELFN1	8.91e-04	9	149	2	EFO_0021059
Disease	Aortic Valve Insufficiency	FN1 FSTL1	1.35e-03	11	149	2	C0003504
Disease	obesity	NPC1 TTC28 ZDBF2 ERI1 PTPRG EXOC4	1.45e-03	241	149	6	EFO_0001073
Disease	homocysteine measurement	DCHS2 MFN2 TRDMT1	1.63e-03	46	149	3	EFO_0004578
Disease	type 2 diabetes mellitus (is_implicated_in)	SORBS1 ITGA2 SLC2A2 GHR PIK3C2G	1.80e-03	171	149	5	DOID:9352 (is_implicated_in)
Disease	Liver Cirrhosis, Experimental	PRUNE2 COL12A1 APP SMC5 GHR AP3S1 FSTL1 LOXL2 C1QA GNAI2 IL2RB	1.97e-03	774	149	11	C0023893
Disease	cervical carcinoma	PRUNE2 DDR2 FSIP2 TRDMT1 EXOC4	2.36e-03	182	149	5	EFO_0001061
Disease	total lipids in medium VLDL	ITIH3 ITIH4 TP53BP1	2.59e-03	54	149	3	EFO_0022153
Disease	Metastatic melanoma	PRKD1 MAP3K15 TAF1	2.59e-03	54	149	3	C0278883
Disease	lymphocyte count	FN1 PCDHGB7 TTC28 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGA6 SBNO2 ACSBG1 PCDHGA12 CDK13 MCM3AP PCDHGB4 GNAI2 SSH2 HTT	3.05e-03	1464	149	16	EFO_0004587
Disease	chronic lymphocytic leukemia	MYNN APP FREM1 BANK1	3.16e-03	119	149	4	EFO_0000095
Disease	health study participation	NPC1 CEP170 CELSR3 BANK1 EXOC4	3.18e-03	195	149	5	EFO_0010130
Disease	Malignant neoplasm of breast	FN1 PCDHGB6 PCDHB15 RNF149 ARFGEF2 ABCB6 SORBS1 SLC2A2 TRMT2A AKAP9 LOXL2 GNAI2 TP53BP1	3.20e-03	1074	149	13	C0006142
Disease	glucose measurement	OGDH SLC2A2 PIK3C2G GNAI2 MAP3K15 NMT1 PROX1	3.27e-03	380	149	7	EFO_0004468
Disease	erythritol measurement	DDR2 BANK1	3.28e-03	17	149	2	EFO_0021171
Disease	body fat percentage	NPC1 TRPM2 SLC2A2 PTPRG WDR41 SSH2 NMT1 HTT	3.46e-03	488	149	8	EFO_0007800
Disease	Global developmental delay	FHIP2A GTPBP2 PACS2 TAF1	4.70e-03	133	149	4	C0557874
Disease	central corneal thickness	COL6A3 COL12A1 ITGA2 SMC5 LOXL2 DCBLD2	4.95e-03	309	149	6	EFO_0005213

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTENSEEYGNIIVTL	PTPRG	966	P23470
QEPEDYISVIQSIIF	BANK1	141	Q8NDB2
SDIQVQYVQLAPVSD	BANP	476	Q8N9N5
TYTIELENPNSEEVE	CEP170	501	Q5SW79
IEDTFQQYVRPEINT	ERI1	166	Q8IV48
QQVNESEPVYLEVFS	FCER1A	96	P12319
YINSSQRVESTVIPE	AKAP9	66	Q99996
YEAIPQQINSTIVDL	ELFN1	51	P0C7U0
VIFDTVITNQEEPYQ	C1QA	131	P02745
TQEQEVYQVPPSVQR	NEDD9	126	Q14511
VYPELQITNVVEANQ	APP	76	P05067
QVTDANGYPQISLEV	COL16A1	121	Q07092
SQVEATEPQDVVVYD	DUSP8	76	Q13202
TEPQDVVVYDQSTRD	DUSP8	81	Q13202
QQLTEFQVDEIYTVP	GTPBP2	406	Q9BX10
TQTTVQDDPEQFEVI	ARFGEF2	626	Q9Y6D5
VQAQEPNVKETYDSS	CENPU	371	Q71F23
PQSYTLQVHEEDQDV	ABCB6	211	Q9NP58
ESSEPVNTNVVLRYD	CHRNA9	126	Q9UGM1
QPYSEDTQQQIIRET	AP3S1	21	Q92572
QGYITNQSPESIVEE	ANKRD17	796	O75179
NTTVSQDPETELYAV	CD80	186	P33681
TPLVEYEDVSSQSEQ	CDK13	141	Q14004
NNEIQFTEETEPTYT	C16orf46	16	Q6P387
TFEYPSNAVEEVTQN	ITIH4	466	Q14624
VTNTNEYESILPERE	RAD51AP2	896	Q09MP3
TSTAYQEQRPQVEQV	NOXA1	261	Q86UR1
QQAIELTQEEPYSDI	RAD21	606	O60216
YDSETRNPVSEELQV	RFWD3	196	Q6PCD5
SEAVQQTVEESSPVY	PIK3C2G	1306	O75747
DREQVPSYNITVTAT	PCDHGA12	411	O60330
DREQTPEYNVTIVAT	PCDHGB6	411	Q9Y5F9
EQNPEYNITVTATDR	PCDHGB4	411	Q9UN71
DREQTPEYNVTIAAT	PCDHGB7	411	Q9Y5F8
NRNVYEVEPTVSVVQ	MEGF10	1071	Q96KG7
LYPVEVEIVDINDNT	PCDHGA6	116	Q9Y5G7
DSDEQDPQEVTYTQL	KIR2DL2	291	P43627
SQSVINYVEEENIPA	KIDINS220	6	Q9ULH0
TEPVINGTSVVLQYE	KCNC2	261	Q96PR1
NGTSVVLQYEIETDP	KCNC2	266	Q96PR1
IQENVDISTVYQIFP	PRKD1	571	Q15139
YPQENIIDTFVVENA	NMT1	376	P30419
PENVIQLLSENYTAV	NELFCD	76	Q8IXH7
EQPYSQLSDEQVIEN	DDR2	786	Q16832
RTTYVNQNEEVVSDP	KCNH7	471	Q9NS40
TFYIPEISNLVDIQE	HERC3	611	Q15034
VTYEVQTDVLSQVQE	CFAP65	1331	Q6ZU64
SEEEEVTYTVINQFQ	EXD1	71	Q8NHP7
DYTVTEIPDTINDLQ	MCM3AP	1531	O60318
QVVINPNFEVAESDY	LOXL2	711	Q9Y4K0
DVTVYLFDQETPTNE	LMTK3	1356	Q96Q04
NPENTERIYQVVDSV	FSIP2	6411	Q5CZC0
DTILVNGESVQIPYN	MUC19	546	Q7Z5P9
TIYLTAEPNTLEVQD	PIP5K1B	516	O14986
NENINTNPITPEVDY	EVI2A	56	P22794
YIINPSLEVNSDTVE	FREM1	1706	Q5H8C1
INNYVINSTDELPTI	SLC2A2	56	P11168
STAIELVQTNSEYDP	METTL2B	216	Q6P1Q9
TVQYPSDILENASVE	MYNN	196	Q9NPC7
YVNSNEIVPVSSLQE	MEIKIN	306	A0A087WXM9
VDEESFQYPSQQATV	HMGXB4	206	Q9UGU5
LDREQTPEYNVTITA	PCDHGB5	406	Q9Y5G0
DREQIPEYNVTITAT	PCDHGB3	411	Q9Y5G1
SEVTQAPGQYTVDVE	OVOS2	1276	Q6IE36
IVTGYTDQQPDIISN	PCDH10	856	Q9P2E7
AVQDTPDIVSRITQY	PACS2	626	Q86VP3
EFVQALYEVQVPENS	PCDHB15	241	Q9Y5E8
QPSSQYFVEQEKVVS	OR5J2	261	Q8NH18
IIYIQEPSDVVNSLD	ITGA2	741	P17301
IVEQIPTYVEYSEQT	PLBD1	376	Q6P4A8
YRNAELDPVTTEEQV	MFN2	61	O95140
STAIELVQTNSEYDP	METTL2A	216	Q96IZ6
VYVTDVNDNDPVLEQ	DCHS2	2026	Q6V1P9
LNVTATEDYVDPVTN	NPC1	121	O15118
TEDYVDPVTNQTKTN	NPC1	126	O15118
DQTEVVIYVVERSPN	NUP54	236	Q7Z3B4
SQGVVNQPEYEEEIS	OGDH	546	Q02218
GYLQDTVVTPLTQQE	EXOC4	361	Q96A65
EVSPSAEQLVQVYEL	HTT	346	P42858
PYTDVNIVTIRENTE	IDH3A	136	P50213
ADESSPVYTQVVENT	C2CD3	1671	Q4AC94
QLTDLVPNTEYAVTV	COL12A1	1531	Q99715
IQPSLNQEDIYITTE	GHR	556	P10912
QPIYENVNVVSGDEV	FCRL1	366	Q96LA6
YAVEENQESTPVVIQ	FN1	881	P02751
FVEQNETAINITTYP	FSTL1	171	Q12841
ETAINITTYPDQENN	FSTL1	176	Q12841
IQVGLVQYNSDPTDE	COL6A3	1676	P12111
ETLTPDTQYEFQVRV	IL2RB	196	P14784
PEITQDEAEIYSLTN	C7orf77	11	A4D0Y5
DIRPAEVQQEVVVSY	ACSBG1	311	Q96GR2
QQELLSVDESVYTPD	APPL2	251	Q8NEU8
ETVYSNSEVRNLNVP	CCP110	106	O43303
VEVYNLTADPDQITN	GNS	476	P15586
EIVQVEIFSTNPDLY	IQUB	196	Q8NA54
TVTVQTGLDQYQQVP	IQUB	226	Q8NA54
AYTAEQENEPTVGII	KIF4B	101	Q2VIQ3
EVSYVQCEASQPVQT	KPRP	116	Q5T749
DELVYQVPQSTQEVS	DCBLD2	746	Q96PD2
VIEESSVYNQVSLPL	DCLRE1A	446	Q6PJP8
ILDQPYDVNLQVTSV	FHIP2A	646	Q5W0V3
QEYVIVVQATSAPLV	CELSR3	1136	Q9NYQ7
DTNRCVEPYIQVSEN	EFEMP2	311	O95967
DSDEQDPQEVTYTQL	KIR2DL1	291	P43626
AQDIRYPVDVTITND	NHLRC1	171	Q6VVB1
YELETPLNQTDNTVT	PTPRM	591	P28827
YIVNPVNDTVVLSEN	PCDH11Y	391	Q9BZA8
LYEVAVLENTPVNSV	PCDHB3	246	Q9Y5E6
TQVQNITVTQYDPEE	MUC17	4301	Q685J3
QPSYVSINNEAEERT	MAP3K15	541	Q6ZN16
IPDNEYETSETFQII	FREM3	1846	P0C091
PREIINTYTEAVQTV	XAB2	371	Q9HCS7
QVNTPAAEVLYTVIQ	TRMT2A	411	Q8IZ69
SVLQTAEDVQVENIY	TRDMT1	306	O14717
LVYQQEDPSVTCDQV	PRUNE2	331	Q8WUY3
IYQFPTDEETVAEIN	SEPTIN11	211	Q9NVA2
SVSLQTEERVQPEYQ	RGP1	256	Q92546
YQEVTNTDLIPNTQI	TAF1B	41	Q53T94
EGTVQQPQASVLYED	TAF1	1701	P21675
TYDVNRESPGNVQIV	ITIH3	251	Q06033
VQYPQDVTTFNIDDQ	GANAB	731	Q14697
ERIAQSDYIPTQQDV	GNAI2	161	P04899
NPQGSEQDVEYSVVQ	PROX1	46	Q92786
NPVDSYTVELTQAES	FSD2	496	A1L4K1
RTNEIVEEQYTPQSL	SCG2	181	P13521
VEEQYTPQSLATLES	SCG2	186	P13521
SSVEVSPDIYQQVRD	SATB2	356	Q9UPW6
QPEEYSSVVSEVVLQ	SHLD2	541	Q86V20
SEIIPETNQIYENDN	SGO2	816	Q562F6
VSYQEQSVQSQPEEE	SBNO2	171	Q9Y2G9
AQVDYVEPSQNTISL	SUPT5H	291	O00267
QEAVEPTVYVGTAVN	MED13	591	Q9UHV7
TLTVDTDEIQVNYPG	NDUFAF5	236	Q5TEU4
TPNTYLRVNVADEVQ	ADD2	436	P35612
VVNIEYVDPQTNLTV	RNF149	41	Q8NC42
IAPSVDIQEQVYRVQ	ZWILCH	451	Q9H900
VYNDSRVSPVSENQV	USP21	531	Q9UK80
EVPTYETDISSTQLQ	ZNF573	111	Q86YE8
YVPETEQETNVASEI	WDFY3	2396	Q8IZQ1
DLRTVIPYQESETQA	SSH2	986	Q76I76
DTLEPLSTIQYNVVD	TRPM2	1291	O94759
QPDQVTAVRVYVNSS	SIDT1	71	Q9NXL6
TSQPETAVIYTPQEN	TKTL2	476	Q9H0I9
EIQQTSEEDNPYTPT	SORBS1	426	Q9BX66
DSEIIYVSNIPLQSV	ZDBF2	1326	Q9HCK1
ETQPQEEYEIINVEV	PREPL	101	Q4J6C6
SQSQDVEENTVPYEV	TP53BP1	176	Q12888
DTVQVIRTQNPQSYV	PKHD1L1	581	Q86WI1
PYQVGTELSIQISED	ZNF226	131	Q9NYT6
QQDSDPYSPVTIDQI	TTC28	1211	Q96AY4
VTLQYNVTLPATEEQ	TRAM1	51	Q15629
SDPSIRTQVYQDLEE	ZC3H12C	491	Q9C0D7
EQNQTISPLSTYEES	ZNF148	406	Q9UQR1
AEQTLPQEYQTQVPT	SMC5	831	Q8IY18
TEQNLSYSEEPITEI	TPMT	101	P51580
LQTIGEEQTQNPYTE	WDR41	21	Q9HAD4
EVENNVYSQATGVVP	TTLL5	1121	Q6EMB2
NVSVEVVNTLYEDIQ	DUSP18	51	Q8NEJ0
NITNVEVETEPFLTY	KCNC3	336	Q14003